Application for quotation of securities - CHM

Sep 21, 2026 at 10:32 PM EDT · Issued by Chimeric Therapeutics Limited via ASX

Filed with ASX · Sep 21, 2026 at 10:32 PM EDT · 6 pages · English

On 6ix: 6ix.com/news/application-for-quotation-of-securities-chm-1

Release

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity nameCHIMERIC THERAPEUTICS LIMITEDAnnouncement TypeNew announcementDate of this announcementTuesday September 22, 2026The +securities to be quoted are:Total...

Chimeric Therapeutics Limited on 6ix

Earlier from Chimeric Therapeutics

Appendix 4E and Preliminary Final ReportAug 31
CHM ceases enrolment in Phase 1 trial and Company updateAug 18
Trading HaltAug 16
Quarterly Activities/Appendix 4C Cash Flow ReportJul 31
Chimeric receives $1.62M advance on FY26 R&D tax incentiveJul 29

Later from Chimeric Therapeutics

FY2026 Annual Report, creditor update and Board changesSep 30
Initial Director's Interest Notice - RMOct 5
Final Director's Interest Notice - BGOct 5
Final Director's Interest Notice - LROct 5
Notice of initial substantial holder for CHMOct 6

All Chimeric Therapeutics news releases

Follow Chimeric Therapeutics into a list and get an email when it puts out news.

Follow Chimeric Therapeutics